Strizek, Brigitte ORCID: 0000-0003-3625-7097, Spicher, Theresa, Gottschalk, Ingo, Bockenhoff, Paul, Simonini, Corinna, Berg, Christoph, Gembruch, Ulrich ORCID: 0000-0001-8284-4669 and Geipel, Annegret (2022). Vesicoamniotic Shunting before 17+0 Weeks in Fetuses with Lower Urinary Tract Obstruction (LUTO): Comparison of Somatex vs. Harrison Shunt Systems. J. Clin. Med., 11 (9). BASEL: MDPI. ISSN 2077-0383

Full text not available from this repository.

Abstract

(1) Background: The aim of this study was to compare perinatal outcomes and complication rates of vesicoamniotic shunting (VAS) before 17 + 0 weeks in isolated LUTO (lower urinary tract obstruction) with the Somatex (R) intrauterine shunt vs. the Harrison fetal bladder shunt. (2) Methods: This is a retrospective cohort study in two tertiary fetal medicine centers. From 2004-2014, the Harrison fetal bladder shunt was used, and from late 2014-2017, the Somatex shunt. Obstetrics and pediatric charts were reviewed for complications, course of pregnancy, perinatal outcome, and postnatal renal function. (3) Results: Twenty-four fetuses underwent VAS with a Harrison (H) shunt and 33 fetuses with a Somatex (S) shunt. Live birth rates and survival to last follow-up were significantly higher in the Somatex group, at 84.8% and 81.8%, respectively, vs. 50% and 33.3% in the Harrison group (p = 0.007 and p < 0.001). The dislocation rate in the Somatex group (36.4%) was significantly lower than in the Harrison group (87.5%) (p < 0.001). The median time to dislocation was significantly different, at 20.6 days (H) vs. 73.9 days (S) (p = 0.002), as was gestational age at dislocation (17 (H) vs. 25 (S) weeks, p < 0.001). Renal function was normal in early childhood in 51% (S) vs. 29% (H) (p = 0.11). (4) Conclusions: VAS before 17 + 0 weeks gestational age with a Somatex shunt improves perinatal survival significantly and might even have a positive effect on renal function, probably due to the lower dislocation rates. A normal amount of amniotic fluid in the third trimester was the best predictor of normal renal function in early childhood.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Strizek, BrigitteUNSPECIFIEDorcid.org/0000-0003-3625-7097UNSPECIFIED
Spicher, TheresaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Gottschalk, IngoUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Bockenhoff, PaulUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Simonini, CorinnaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Berg, ChristophUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Gembruch, UlrichUNSPECIFIEDorcid.org/0000-0001-8284-4669UNSPECIFIED
Geipel, AnnegretUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-663975
DOI: 10.3390/jcm11092359
Journal or Publication Title: J. Clin. Med.
Volume: 11
Number: 9
Date: 2022
Publisher: MDPI
Place of Publication: BASEL
ISSN: 2077-0383
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
FETAL MEGACYSTIS; OUTCOMES; INTERVENTION; ETIOLOGIES; MANAGEMENTMultiple languages
Medicine, General & InternalMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/66397

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item